Dr. Yvonne Saenger, MD

• Hematology

• Medical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Johns Hopkins School Of Medicine

  Fellowship Hospital, 2009

• New York Presbyterian Hospital Columbia University Medical Center

  Internship Hospital, 2002

• Columbia University Vagelos College Of Physicians And Surgeons

  Medical School, 2001

• English

• French

• Spanish

• Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders, 2021-04-22

• Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma, 2019-01-15

• Biomarkers predictive of survival and response to immune checkpoint inhibitors (ICI) in melanoma, 2019-10-20

• Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma, 2021-02-02

• Quantitative Analysis of Immune Infiltrates in Primary Melanoma, 2018-02-21

• Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy, 2019-01-15

• An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma, 2019-11-29

• Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma, 2019-02-11

• InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma, 2023-04-03

• Stable liver graft post anti-PD1 therapy as a bridge to transplantation in an adolescent with hepatocellular carcinoma Anti-PD1 before pediatric liver transplant, 2021-12-15

• Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment (TIME) and identifies a combination biomarker for primary melanoma, 2020-01-16

• Prognostic and predictive immunohistochemistry-based biomarkers in cancer and immunotherapy, 2019-01-17

• Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas, 2015-06-16

• Quality assessment of stereotactic radiosurgery of a melanoma brain metastases model using a mouse-like phantom and the small animal radiation research platform, 2017-05-19

• 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two National Harbor, MD, USA. 9-13 November 2016, 2016-11-16

• Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence, 2021-09-30

• Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid, 2016-04-19

• Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition, 2018-04-06

• 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts National Harbor, MD, USA. 9-13 November 2016, 2016-12-08